Image (723c5298 429e 4bd0 A2d8 C180bfec9c0d 01)
Meclizine Hydrochloride Tablet
Product Images NDC 70771-1539
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Meclizine Hydrochloride (NDC 70771-1539). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Label (723c5298 429e 4bd0 A2d8 C180bfec9c0d 02)
This text appears to be a drug label for a medication with the NDC code 70774-1539. The medication contains meclizine and is indicated for vertigo. The recommended dosage is between 25 mg to 100 mg in divided doses daily, depending on the clinical response. It is advised to store the medication at 20°C to 25°C and to keep it in a tightly sealed, light-resistant container. This medication is to be dispensed only to patients with a valid prescription from a doctor or healthcare professional. The drug is manufactured by Cadia Healthcare Ltd. in India.*
Label (723c5298 429e 4bd0 A2d8 C180bfec9c0d 03)
This is a description of Meclizine Hydrochloride, a medication available as tablets containing 25mg of Meclizine Hydrochloride. It is used for the treatment of vertigo, with dosages ranging from 25g to 100mg depending on the response of the patient. It should be stored at 20° to 25°C and dispensed in a tightly sealed, light-resistant container. The medication is manufactured by Cadia Healthcare Ltd in India and is available by prescription only.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
